Chen et al. found a higher prevalence of Cyclin E mutations in TNBC (52% in The Cancer Genome Atlas and 40% in the METABRIC database) compared to ERα+ breast cancer (3% in TCGA and 2.3% in METABRIC) [83]. The gene discussed is ESR1; the disease is breast carcinoma.